about
The role of conserved Glu residue on cyclotide stability and activity: a structural and functional study of kalata B12, a naturally occurring Glu to Asp mutantCharacterization of a Novel α-Conotoxin TxID from Conus textile That Potently Blocks Rat α3β4 Nicotinic Acetylcholine ReceptorsOxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand designThe radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilmsAccurate de novo design of hyperstable constrained peptidesSynergistic Activity of the Plant Defensin HsAFP1 and Caspofungin against Candida albicans Biofilms and Planktonic CulturesHepatic phospholipid changes induced by sustained oxygen supplementation.Functional implications of modifying RyR-activating peptides for membrane permeability.Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling.α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors.Malignant hyperthermia mutation sites in the Leu2442-Pro2477 (DP4) region of RyR1 (ryanodine receptor 1) are clustered in a structurally and functionally definable areaThe self-association of the cyclotide kalata B2 in solution is guided by hydrophobic interactions.31P MAS-NMR of human erythrocytes: independence of cell volume from angular velocity.Translational diffusion of cyclic peptides measured using pulsed-field gradient NMR.Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer.Identification of survival-promoting OSIP108 peptide variants and their internalization in human cells.Conformational Flexibility Is a Determinant of Permeability for Cyclosporin.Stabilization of the cysteine-rich conotoxin MrIA by using a 1,2,3-triazole as a disulfide bond mimetic.Effects of an alpha-helical ryanodine receptor C-terminal tail peptide on ryanodine receptor activity: modulation by Homer.Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.Defense Peptides Engineered from Human Platelet Factor 4 Kill Plasmodium by Selective Membrane DisruptionSingle Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor AntagonistNMR Structure of μ-Conotoxin GIIIC: Leucine 18 Induces Local Repacking of the N-Terminus Resulting in Reduced Na Channel PotencyDiscovery and Characterization of Cyclotides from Rinorea SpeciesHepatic oxygen supplementation as therapy in cirrhotic liver disease31P and 1H NMR spectroscopic studies of liver extracts of carbon tetrachloride-treated ratsStructural and functional characterization of interactions between the dihydropyridine receptor II-III loop and the ryanodine receptor1H, 13C and 15N assignments for the II-III loop region of the skeletal dyhydropyridine receptorCalcium-Mediated Allostery of the EGF FoldEnhanced Activity against Multidrug-Resistant Bacteria through Coapplication of an Analogue of Tachyplesin I and an Inhibitor of the QseC/B Signaling PathwayMolecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptorsCharacterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer PropertiesStructure and Activity Studies of Disulfide-Deficient Analogues of αO-Conotoxin GeXIVA
P50
Q27667166-C3BC6A68-5F25-44FD-894F-F58E0C58C3CFQ27680549-3B3C4236-98F1-4149-9D68-61ECA02DD6B5Q27680631-847E6A28-60BE-4976-AA48-7910E8AB93D4Q27702867-6B74AA7F-C844-40BE-86B5-B0C102C2CC73Q27728065-B6CAC4AF-96E0-4464-AAF7-464D29962BF9Q28547086-E5FD1FCC-0252-4574-A6AB-4CC345FFFBB4Q34994381-008F1D56-9B85-43D6-9B5D-BC37A33A25AAQ35048695-B7ADE930-2926-4A95-ADA7-3CF0D9EE2A64Q35910100-AB1B12E9-3AED-4AB8-B70D-B3966BF11864Q37346777-DC7B4E81-BA3C-4482-8DC8-5DC80ECBA883Q39605557-C0E2AD3A-94AC-4F29-AC6C-A91D3776E0EBQ41083180-12A6C41D-3C44-48B7-AC09-C989AFEE9AA8Q42280887-6814FB32-A62C-438E-8317-ADD2821ED435Q45034931-D7208F64-1679-447E-989C-9A1617E95660Q46909798-ECF42FAE-5E30-4A11-BA6F-5DC116C5D943Q47886865-18C2C6A3-0C29-4625-A860-4572C1E30368Q49031666-05295731-CE99-42CF-AAEF-DB173BBF95ADQ50200262-254FD267-FABD-4BB1-92B4-489697420AACQ51027198-81EEA9BD-E7B8-4E38-A9E3-4859E06D35EBQ52571077-99ED293A-3B48-492B-814B-75EC5BCF8882Q52615555-30F3EB48-D181-48F9-9E3D-C584A6AE70BCQ56364460-DD346B1F-5537-4892-8CED-49633FC8344FQ57290312-19C16B9D-B11C-4CBD-9A0A-122E72B71929Q58582851-D2D6A529-6DB4-4300-9828-47CDAB7BD2BFQ58617046-0C5549B9-89AE-495D-9318-C5EC6AF2FDB0Q60687077-295928AA-0378-4991-89BD-9F78EAAAA58EQ73071890-9461BC30-E69D-423C-B32A-91B482123CAFQ79249276-C0A26354-C3A8-4F8C-B534-4E9B967575EEQ80927446-4DA69176-6FFF-4759-AE97-CF3344E39418Q88532094-D9D38134-9123-4313-951C-CA0887728116Q89463998-70FF437F-C163-4D31-98D5-51DDC384E296Q91699841-21820E2E-473E-47D5-A915-A8E3A2CAF008Q92906753-07F80D4E-90DC-4712-86A5-51D1A6622FACQ92966350-D8048885-5A52-4A7C-A299-31AF122A32F4
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peta J Harvey
@ast
Peta J Harvey
@en
Peta J Harvey
@es
Peta J Harvey
@nl
type
label
Peta J Harvey
@ast
Peta J Harvey
@en
Peta J Harvey
@es
Peta J Harvey
@nl
altLabel
Peta Harvey
@en
prefLabel
Peta J Harvey
@ast
Peta J Harvey
@en
Peta J Harvey
@es
Peta J Harvey
@nl
P106
P1153
36852333500
P21
P31
P496
0000-0003-4735-6242